|
MYCBP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.026800E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.550200E-02 |
| Normal-vs-Stage2 |
1.158450E-01 |
| Normal-vs-Stage3 |
8.37540000020454E-07 |
| Normal-vs-Stage4 |
2.2312999999885E-06 |
| Stage1-vs-Stage2 |
9.360200E-01 |
| Stage1-vs-Stage3 |
3.398500E-04 |
| Stage1-vs-Stage4 |
2.255500E-03 |
| Stage2-vs-Stage3 |
1.949980E-02 |
| Stage2-vs-Stage4 |
2.436200E-02 |
| Stage3-vs-Stage4 |
8.895200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.623700E-04 |
| Normal-vs-AfricanAmerican |
1.462010E-01 |
| Normal-vs-Asian |
4.317800E-01 |
| Caucasian-vs-AfricanAmerican |
5.844600E-01 |
| Caucasian-vs-Asian |
4.206100E-02 |
| AfricanAmerican-vs-Asian |
2.963200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.419600E-04 |
| Normal-vs-Female |
9.566200E-04 |
| Male-vs-Female |
8.929600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.273840E-02 |
| Normal-vs-Age(41-60Yrs) |
1.735920E-02 |
| Normal-vs-Age(61-80Yrs) |
8.05210000000001E-05 |
| Normal-vs-Age(81-100Yrs) |
5.613300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.787200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.813000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.710400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.094300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.322100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.722600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.752200E-01 |
| Normal-vs-Grade 2 |
1.990480E-02 |
| Normal-vs-Grade 3 |
1.156160E-04 |
| Normal-vs-Grade 4 |
7.95789999999963E-05 |
| Grade 1-vs-Grade 2 |
7.528100E-02 |
| Grade 1-vs-Grade 3 |
2.422000E-02 |
| Grade 1-vs-Grade 4 |
7.243600E-03 |
| Grade 2-vs-Grade 3 |
4.878500E-02 |
| Grade 2-vs-Grade 4 |
1.057720E-02 |
| Grade 3-vs-Grade 4 |
3.213400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.067900E-02 |
| Normal-vs-ccB subtype |
1.059340E-03 |
| ccA subtype-vs-ccB subtype |
9.795900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.752900E-04 |
| Normal-vs-N1 |
2.254000E-02 |
| N0-vs-N1 |
6.411600E-01 |
|
|
